FDA Approves New Nasal Spray, Opvee, to Reverse Overdoses

TUESDAY, May 23, 2023 -- The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose.
To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will be available to...